Cathie Wood, CEO of Ark Investment Management, typically focuses on small- and mid-cap technology stocks. She sometimes ...
According to ARK’s daily trading disclosure for April 4, Wood’s flagship ARK Innovation ETF (ARKK) bought nearly 55,000 ...
The ARKK fund bought 69,011 shares of CRISPR Therapeutics AG and 142,713 shares of Beam Therapeutics Inc. Based on the last ...
EDT Cathie Wood’s ARK Investment buys 143K shares of Beam Therapeutics (BEAM) todayDon't Miss Our End of Quarter Offers: Discover the ...
Investor's Business Daily on MSN2d
Cathie Wood, ARK Invest Double Down On These 2 Stocks Amid Sell-OffCathie Wood, ARK Invest buy two stocks on Wednesday, Thursday as Trump tariffs rake the market. Wood previously warned of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback